Pancreatic Cancer Research

ResearcherSouth Texas Veterans Health Care SystemActive in the last 2 years

Jingjing Gong

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1756-2638; OpenAlex author ID A5060511465. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
9
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 2

  1. STN1 facilitates metastasis by promoting transcription of EMT-activator ZEB1 in pancreatic cancer. Co-author DOI 10.1038/s41467-025-63083-0↗
  2. Combined targeting of STAT3/NF-κB/COX-2/EP4 for effective management of pancreatic cancer. Co-author DOI 10.1158/1078-0432.ccr-13-1664↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Mo Chen · 1 shared paper, 2025 · strength 0.25
  2. Di Dong · 1 shared paper, 2025 · strength 0.25
  3. Yuxin Yin · 1 shared paper, 2025 · strength 0.25
  4. Susan M Fischer · 1 shared paper, 2014 · strength 0.04
  5. James W. Freeman · 1 shared paper, 2014 · strength 0.04
  6. Addanki Pratap Kumar · 1 shared paper, 2014 · strength 0.04
  7. Divya Chakravarthy · 1 shared paper, 2014 · strength 0.04
  8. Huamin Wang · 1 shared paper, 2014 · strength 0.04
  9. Scott Kopetz · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.